Amneal to Report Second Quarter 2024 Results on August 9, 2024
July 11 2024 - 4:05PM
Business Wire
Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) announced today that
the Company will release its second quarter 2024 financial results
on Friday, August 9, 2024, prior to market open. The Company will
host a conference call and live webcast with the investment
community at 8:30 a.m. Eastern Time.
The financial results and live webcast will be accessible
through the Investor Relations section of the Company's website at
https://investors.amneal.com.
Individuals may register for the conference call by clicking the
link here. Once registered, participants will receive dial-in
details and unique PIN which will allow them to access the
call.
To access the call through a conference line, dial 1 (833)
470-1428 (in the U.S.) or for a list of toll-free international
numbers, visit this link. The access code for the call is
462066.
A replay of the conference call will be posted shortly after the
call and will be available for seven days.
About Amneal
Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX), headquartered in
Bridgewater, NJ, is a global pharmaceutical company. We make
healthy possible through the development, manufacturing, and
distribution of a diverse portfolio of over 280 pharmaceutical
products, primarily within the United States. In its Generics
segment, the Company is expanding across a broad range of complex
product categories and therapeutic areas, including injectables and
biosimilars. In its Specialty segment, Amneal has a growing
portfolio of branded pharmaceuticals focused primarily on central
nervous system and endocrine disorders, with a pipeline focused on
unmet needs. Through its AvKARE segment, the Company is a
distributor of pharmaceuticals and other products for the U.S.
federal government, retail, and institutional markets. For more
information, please visit www.amneal.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240711590201/en/
Investor Contact Anthony DiMeo VP, Investor Relations
& Media anthony.dimeo@amneal.com
Amneal Pharmaceuticals (NYSE:AMRX)
Historical Stock Chart
From Oct 2024 to Nov 2024
Amneal Pharmaceuticals (NYSE:AMRX)
Historical Stock Chart
From Nov 2023 to Nov 2024